Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Tubular β-catenin and FoxO3 interactions protect in chronic kidney disease
Stellor Nlandu-Khodo, Yosuke Osaki, Lauren Scarfe, Haichun Yang, Melanie Phillips-Mignemi, Jane Tonello, Kenyi Saito-Diaz, Surekha Neelisetty, Alla Ivanova, Tessa Huffstater, Robert McMahon, M. Mark Taketo, Mark deCaestecker, Balakuntalam Kasinath, Raymond C. Harris, Ethan Lee, Leslie S. Gewin
Stellor Nlandu-Khodo, Yosuke Osaki, Lauren Scarfe, Haichun Yang, Melanie Phillips-Mignemi, Jane Tonello, Kenyi Saito-Diaz, Surekha Neelisetty, Alla Ivanova, Tessa Huffstater, Robert McMahon, M. Mark Taketo, Mark deCaestecker, Balakuntalam Kasinath, Raymond C. Harris, Ethan Lee, Leslie S. Gewin
View: Text | PDF
Research Article Cell biology Nephrology

Tubular β-catenin and FoxO3 interactions protect in chronic kidney disease

  • Text
  • PDF
Abstract

The Wnt/β-catenin signaling pathway plays an important role in renal development and is reexpressed in the injured kidney and other organs. β-Catenin signaling is protective in acute kidney injury (AKI) through actions on the proximal tubule, but the current dogma is that Wnt/β-catenin signaling promotes fibrosis and development of chronic kidney disease (CKD). As the role of proximal tubular β-catenin signaling in CKD remains unclear, we genetically stabilized (i.e., activated) β-catenin specifically in murine proximal tubules. Mice with increased tubular β-catenin signaling were protected in 2 murine models of AKI to CKD progression. Oxidative stress, a common feature of CKD, reduced the conventional T cell factor/lymphoid enhancer factor–dependent β-catenin signaling and augmented FoxO3-dependent activity in proximal tubule cells in vitro and in vivo. The protective effect of proximal tubular β-catenin in renal injury required the presence of FoxO3 in vivo. Furthermore, we identified cystathionine γ-lyase as a potentially novel transcriptional target of β-catenin/FoxO3 interactions in the proximal tubule. Thus, our studies overturned the conventional dogma about β-catenin signaling and CKD by showing a protective effect of proximal tubule β-catenin in CKD and identified a potentially new transcriptional target of β-catenin/FoxO3 signaling that has therapeutic potential for CKD.

Authors

Stellor Nlandu-Khodo, Yosuke Osaki, Lauren Scarfe, Haichun Yang, Melanie Phillips-Mignemi, Jane Tonello, Kenyi Saito-Diaz, Surekha Neelisetty, Alla Ivanova, Tessa Huffstater, Robert McMahon, M. Mark Taketo, Mark deCaestecker, Balakuntalam Kasinath, Raymond C. Harris, Ethan Lee, Leslie S. Gewin

×

Figure 1

Increased β-catenin signaling in proximal tubules protects against AKI to CKD injury.

Options: View larger image (or click on image) Download as PowerPoint
Increased β-catenin signaling in proximal tubules protects against AKI t...
(A) H&E sections of Ggt-Cre Ctnnb1ex3fl/fl mice and floxed controls without injury as well as 6 weeks after aristolochic acid nephropathy (AAN). Scale bars: 50 μm. (B) Injury was scored by colleagues who did not know the identity of the genotype (see Methods for scoring system). (C) KIM-1 (Havcr1) levels were measured by quantitative PCR, normalized to Gapdh, in cortical tissue from both uninjured and aristolochic acid–treated mice. (D and E) Picrosirius red (Sirius Red) staining measured collagen (red staining) and was quantified using ImageJ (NIH). Scale bar: 50 μm. (F) Collagen I (Col1a1) transcripts were measured by quantitative PCR (qPCR), normalized to Gapdh, from renal cortices 6 weeks after AAN. (G) Blood urea nitrogen (BUN) was measured from mice either uninjured or 6 weeks after AAN. (H) H&E from Ggt-Cre Ctnnb1ex3fl/fl mice and floxed controls injured by IRI and sacrificed 4 weeks later (see Methods for details). Scale bar: 100 μm for original magnification ×200 and 50 μm for ×400. (I) KIM-1 (Havcr1) expression in renal tissue after IRI injury and (J) BUN levels were measured at the time of sacrifice (4 weeks after IRI). (K) Staining for lotus tetragonolobus (LTL) conjugated to GFP was done. Scale bar: 100 μm for original magnification ×200 and 200 μm for ×100 (K) and quantified by ImageJ (L). (M) Collagen (Col1a1) levels were measured by qPCR from renal tissue 4 weeks after IRI. For all qPCR studies after IRI, the inner medulla was dissected away and discarded. Statistical analyses were done using the Student’s t test with *P < 0.05, **P < 0.01, and ***P < 0.001. For the AAN injury, 1 Ctnnb1ex3fl/fl mouse died before the study’s completion, and for the IRI model, 1 mouse per genotype died prematurely.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts